SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001659617-19-000047
Filing Date
2019-04-16
Accepted
2019-04-16 16:12:10
Documents
1
Period of Report
2019-04-16
Effectiveness Date
2019-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a-proxy2019.htm DEF 14A 501094
  Complete submission text file 0001659617-19-000047.txt   502146
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37758 | Film No.: 19751098
SIC: 2834 Pharmaceutical Preparations